This list is based on the watchlists of people on Stock Events who follow J4T.F. It's not an investment recommendation.
This list is an analysis based on recent market events. It's not an investment recommendation.
Onconetix Inc is a commercial-stage biotechnology company focused on the research, development, and commercialization of solutions for men's health and oncology. The company owns Proclarix, an in vitro diagnostic test for prostate cancer, approved for sale in the European Union. Additionally, it is focused on marketing Proclarix in the U.S. as a lab-developed product. Onconetix operates in one segment: commercial. Geographically, the company generates maximum revenue from Switzerland and the rest from the United Kingdom.
Show more...
FAQ
What is Onconetix stock price today?▼
The current price of J4T.F is €24.65 EUR — it has increased by +0% in the past 24 hours. Watch Onconetix stock price performance more closely on the chart.
What is Onconetix stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on Frankfurt Exchange exchange Onconetix stocks are traded under the ticker J4T.F.
What is Onconetix market cap?▼
Today Onconetix has the market capitalization of 97.35M
When is the next Onconetix earnings date?▼
Onconetix is going to release the next earnings report on November 12, 2026.
What is Onconetix revenue for the last year?▼
Onconetix revenue for the last year amounts to 701,445.63 EUR.
What is Onconetix net income for the last year?▼
J4T.F net income for the last year is -13.92M EUR.
How many employees does Onconetix have?▼
As of September 04, 2026, the company has 2 employees.
In which sector is Onconetix located?▼
Onconetix operates in the Health & Wellness sector.
When did Onconetix complete a stock split?▼
The last stock split for Onconetix was on May 21, 2026 with a ratio of 1:10.
Where is Onconetix headquartered?▼
Onconetix is headquartered in CINCINNATI, United States.